{
    "title": "Viking Therapeutics's NASH drug succeeds in mid-stage trial, shares jump",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12089409/Viking-Therapeuticss-NASH-drug-succeeds-mid-stage-trial.html",
    "date": "2023-05-16",
    "keywords": [
        "drug",
        "disease",
        "liver",
        "inc",
        "study",
        "roy",
        "goal",
        "market",
        "company",
        "tuesday",
        "midstage",
        "trial",
        "type",
        "trade",
        "nordisk",
        "akero",
        "multibillion",
        "dollar",
        "content",
        "vk2809",
        "reduction",
        "fat",
        "fatty",
        "steatohepatitis",
        "nash",
        "fastestgrowing",
        "cause",
        "foundation",
        "biopsy",
        "half",
        "march",
        "obesity",
        "weight",
        "earlystage",
        "position",
        "analyst",
        "justin",
        "zelin",
        "concern",
        "time",
        "cost",
        "race",
        "treatment",
        "panel",
        "candidate",
        "friday",
        "latestage",
        "food",
        "decision",
        "reporting",
        "raghav",
        "mahobe",
        "bengaluru",
        "editing",
        "dsouza",
        "rashmi",
        "aich"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}